To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area

European Journal of Cancer

Volumn 48, Issue 6, 2012, Pages 882-888

  Jin, Y ^a   Cai, X Y ^a   Cai, Y C ^a   Cao, Y ^a   Xia, Q ^a   Tan, Y T ^a   Jiang, W Q ^a   Shi, Y X ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Circulating tumour markers; Metastatic nasopharyngeal carcinoma; Prognostic factors; Prognostic score model

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CAPECITABINE; CISPLATIN; FLUOROURACIL; HEMOGLOBIN; IMMUNOGLOBULIN A; LACTATE DEHYDROGENASE; PACLITAXEL; TUMOR MARKER; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CHILD; DISEASE FREE INTERVAL; EPIDEMIC; EPSTEIN BARR VIRUS; FEMALE; GROUPS BY AGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC SCORE MODEL; RISK ASSESSMENT; SCHOOL CHILD; SCORING SYSTEM;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA; CHILD; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84859103755     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.09.004     Document Type: Article

References (28)

1. E.T. Chang, and H.O. Adami The enigmatic epidemiology of nasopharyngeal carcinoma Cancer Epidemiol Biomarkers Prev 15 10 2006 1765 1777 (Pubitemid 44664247)
2. K. Shanmugaratnam, S.H. Chan, and G. de-The Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics Cancer 44 3 1979 1029 1044 (Pubitemid 10242239)
3. M.C. Yu, and J.M. Yuan Epidemiology of nasopharyngeal carcinoma Semin Cancer Biol 12 6 2002 421 429 (Pubitemid 35370755)
4. K. Shanmugaratnam Nasopharyngeal carcinoma: epidemiology, histopathology and aetiology Ann Acad Med Singapore 9 3 1980 289 295 (Pubitemid 11187025)
5. Zong YS, Zhang RF, Chen SH, Xiao ZD, Lao H. Relationship between the histopathology of nasopharyngeal carcinoma (NPC) and the prognosis after radiotherapy [Author's Trans.]. Zhonghua Zhong Liu Za Zhi 1980;2(4):274-277.
6. M. Senba, X.Y. Zhong, M.I. Senba, and H. Itakura EBV and nasopharyngeal carcinoma Lancet 343 8905 1994 1104
7. W.Y. Wang, C.W. Twu, and H.H. Chen Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma Clin Cancer Res 16 3 2010 1016 1024
8. C.W. Twu, W.Y. Wang, and W.M. Liang Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 67 1 2007 130 137
9. M.T. Liu, C.Y. Hsieh, and T.H. Chang Prognostic factors affecting the outcome of nasopharyngeal carcinoma Jpn J Clin Oncol 33 10 2003 501 508
10. F. Chiesa, and F. De Paoli Distant metastases from nasopharyngeal cancer ORL J Otorhinolaryngol Relat Spec 63 4 2001 214 216 (Pubitemid 32621719)
11. S.F. Leung, P.M. Teo, W.W. Shiu, S.Y. Tsao, and T.W. Leung Clinical features and management of distant metastases of nasopharyngeal carcinoma J Otolaryngol 20 1 1991 27 29
12. Y. Tao, F. Bidault, J. Bosq, and J. Bourhis Distant metastasis of undifferentiated carcinoma of nasopharyngeal type Onkologie 31 11 2008 574 575
13. G.B. Gunn, R.D. Villa, and R.R. Sedler Nasopharyngeal carcinoma metastasis to the pituitary gland: a case report and literature review J Neuro-Oncol 68 1 2004 87 90 (Pubitemid 39137354)
14. A.R. Razak, L.L. Siu, and F.F. Liu Nasopharyngeal carcinoma: the next challenges Eur J Cancer 46 11 2010 1967 1978
15. Y. Bensouda, W. Kaikani, and N. Ahbeddou Treatment for metastatic nasopharyngeal carcinoma Eur Ann Otorhinolaryngol Head Neck Dis 128 2 2011 79 85
16. A. Fandi, M. Bachouchi, and N. Azli Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type J Clin Oncol 18 6 2000 1324 1330 (Pubitemid 30159852)
17. E.P. Hui, S.F. Leung, and J.S. Au Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong nasopharyngeal carcinoma study group Cancer 101 2 2004 300 306 (Pubitemid 38890833)
18. Y.K. Ong, D.M. Heng, and B. Chung Design of a prognostic index score for metastatic nasopharyngeal carcinoma Eur J Cancer 39 11 2003 1535 1541 (Pubitemid 36829194)
19. R.K. Tsang, A.C. Vlantis, and R.W. Ho Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review Head Neck 26 7 2004 598 602 (Pubitemid 38857101)
20. M. Yamamoto, H. Kimura, and T. Hironaka Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases J Clin Microbiol 33 7 1995 1765 1768
21. P.M. Teo, W.H. Kwan, W.Y. Lee, S.F. Leung, and P.J. Johnson Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma Cancer 77 12 1996 2423 2431 (Pubitemid 26169137)
22. A.L. McDermott, S.N. Dutt, and J.C. Watkinson The aetiology of nasopharyngeal carcinoma Clin Otolaryngol Allied Sci 26 2 2001 82 92 (Pubitemid 32368223)
23. Y.M. Lo, A.T. Chan, and L.Y. Chan Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA Cancer Res 60 24 2000 6878 6881 (Pubitemid 32059157)
24. X. An, F.H. Wang, and P.R. Ding Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy Cancer 2011
25. S. Turen, E. Ozyar, K. Altundag, I. Gullu, and I.L. Atahan Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy Cancer Invest 25 5 2007 315 321 (Pubitemid 47185070)
26. J.W. Min, S.W. Um, and J.J. Yim The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer J Korean Med Sci 24 2 2009 275 280
27. F. Schindler, P.P. Lajolo, and H. Pinczowski Bone and total alkaline phosphatase for screening skeletal metastasis in patients with solid tumours Eur J Cancer Care (Engl) 17 2 2008 152 156
28. G. Sonpavde, G.R. Pond, and W.R. Berry Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy Urol Oncol 2010